113 related articles for article (PubMed ID: 25975854)
1. Direct coating of culture medium from cells secreting classical swine fever virus E2 antigen on ELISA plates for detection of E2-specific antibodies.
Cheng TC; Pan CH; Chen CS; Chuang KH; Chuang CH; Huang CC; Chu YY; Yang YC; Chu PY; Kao CH; Hsieh YC; Cheng TL
Vet J; 2015 Jul; 205(1):107-9. PubMed ID: 25975854
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of indirect enzyme-linked immunosorbent assay for a screening test to detect antibodies against classical swine fever virus.
Sakoda Y; Wakamoto H; Tamura T; Nomura T; Naito M; Aoki H; Morita H; Kida H; Fukusho A
Jpn J Vet Res; 2012 Aug; 60(2-3):85-94. PubMed ID: 23094583
[TBL] [Abstract][Full Text] [Related]
3. An improved indirect ELISA for specific detection of antibodies against classical swine fever virus based on structurally designed E2 protein expressed in suspension mammalian cells.
Ji S; Luo Y; Zhang T; Shao L; Meng XY; Wang Y; Gao Y; Li Y; Li S; Sun Y; Jin X; Qiu HJ
Arch Virol; 2018 Jul; 163(7):1831-1839. PubMed ID: 29572595
[TBL] [Abstract][Full Text] [Related]
4. Enhancing expression of the classical swine fever virus glycoprotein E2 in yeast and its application to a blocking ELISA.
Cheng CY; Wu CW; Lin GJ; Lee WC; Chien MS; Huang C
J Biotechnol; 2014 Mar; 174():1-6. PubMed ID: 24468422
[TBL] [Abstract][Full Text] [Related]
5. Development of a competitive ELISA using a truncated E2 recombinant protein as antigen for detection of antibodies to classical swine fever virus.
Clavijo A; Lin M; Riva J; Mallory M; Lin F; Zhou EM
Res Vet Sci; 2001 Feb; 70(1):1-7. PubMed ID: 11170845
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of the Erns protein of classical swine fever virus in yeast and its application in an indirect enzyme-linked immunosorbent assay for antibody differentiation of infected from vaccinated animals.
Luo Y; Li L; Austermann-Busch S; Dong M; Xu J; Shao L; Lei J; Li N; He WR; Zhao B; Li S; Li Y; Liu L; Becher P; Sun Y; Qiu HJ
J Virol Methods; 2015 Sep; 222():22-7. PubMed ID: 26005003
[TBL] [Abstract][Full Text] [Related]
7. [Expression and antiviral activity of a chimeric porcinized monoclonal antibody (cHQ06) against E2 protein of classical swine fever virus].
Chen S; Sun H; Li S; Liu P; Ma J; Qiu H
Sheng Wu Gong Cheng Xue Bao; 2017 Aug; 33(8):1235-1243. PubMed ID: 28853251
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a gp 55 (E2) recombinant-based ELISA for the detection of antibodies induced by classical swine fever virus.
Müller A; Depner KR; Liess B
Dtsch Tierarztl Wochenschr; 1996 Nov; 103(11):451-3. PubMed ID: 8968126
[TBL] [Abstract][Full Text] [Related]
9. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral-mediated delivery of classical swine fever virus Erns gene into porcine kidney-15 cells for production of recombinant ELISA diagnostic antigen.
Bhattacharya S; Saini M; Bisht D; Rana M; Bachan R; Gogoi SM; Buragohain BM; Barman NN; Gupta PK
Mol Biol Rep; 2019 Aug; 46(4):3865-3876. PubMed ID: 31016614
[TBL] [Abstract][Full Text] [Related]
11. Development of single dilution immunoassay to detect E2 protein specific classical swine fever virus antibody.
Kumar R; Barman NN; Khatoon E; Kumar S
Vet Immunol Immunopathol; 2016 Apr; 172():50-4. PubMed ID: 27032503
[TBL] [Abstract][Full Text] [Related]
12. Development of an immunochromatographic strip for rapid detection of antibodies against classical swine fever virus.
Li X; Wang L; Shi X; Zhao D; Yang J; Yang S; Zhang G
J Virol Methods; 2012 Mar; 180(1-2):32-7. PubMed ID: 22207080
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits.
Zhang H; Li X; Peng G; Tang C; Zhu S; Qian S; Xu J; Qian P
Vaccine; 2014 Nov; 32(49):6607-13. PubMed ID: 25446823
[TBL] [Abstract][Full Text] [Related]
14. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
Aebischer A; Müller M; Hofmann MA
Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
[TBL] [Abstract][Full Text] [Related]
15. Hypervariable antigenic region 1 of classical swine fever virus E2 protein impacts antibody neutralization.
Liao X; Wang Z; Cao T; Tong C; Geng S; Gu Y; Zhou Y; Li X; Fang W
Vaccine; 2016 Jul; 34(33):3723-30. PubMed ID: 27317266
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
[TBL] [Abstract][Full Text] [Related]
17. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
[TBL] [Abstract][Full Text] [Related]
18. An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV).
van Rijn PA; van Gennip HG; Moormann RJ
Vaccine; 1999 Feb; 17(5):433-40. PubMed ID: 10073720
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of mimotopes of classical swine fever virus E2 glycoprotein using specific anti-E2 monoclonal antibodies.
Batonick M; Loeffen W; Metwally SA; Mayr GA
Virus Res; 2013 Jul; 175(1):12-9. PubMed ID: 23583685
[TBL] [Abstract][Full Text] [Related]
20. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
